drugset / Trial / NCT01965431
Thorough QT Study to Evaluate the Effects of BI 207127 (Deleobuvir) Combined With Faldaprevir on Cardiac Safety Parameters in Healthy Subjects.
RandomizedCrossoverSingle-blindTreatment
Summary
The objective of this study is to evaluate the effect of multiple doses of BI 207127 combined with faldaprevir on cardiac safety parameters in healthy subjects
Timeline
- Start
- 2013-10
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Deleobuvir | Small molecule | — | Oral |
| Subject | Faldaprevir | Small molecule | — | Oral |
| Comparator | Moxifloxacin | Small molecule | — | — |
Indications
No indication recorded.